1h Free Analyst Time
The bacterial disease diagnostics market is forecasted to grow by USD 4.34 billion during 2023-2028, accelerating at a CAGR of 6.78% during the forecast period. The report on the bacterial disease diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by integration of digital health in rapid diagnostics for bacterial disease, high prevalence of infectious diseases, and growing geriatric population.
The bacterial disease diagnostics market is segmented as below:
By Product
- Consumables
- Instruments
By End-user
- Hospitals
- Labs
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the bacterial disease diagnostics market covers the following areas:
- Bacterial disease diagnostics market sizing
- Bacterial disease diagnostics market forecast
- Bacterial disease diagnostics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global bacterial disease diagnostics market: Abbott Laboratories, Accelerate Diagnostics Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Bruker Corp., Danaher Corp., DiaSorin SpA, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., GENERI BIOTECH s.r.o., Great Basin Scientific, Hologic Inc., Meridian Bioscience Inc., QIAGEN NV, Quest Diagnostics Inc., Revvity Inc., Siemens AG, T2 Biosystems Inc., and Takara Bio Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing demand for portable analytical instruments."
According to the report, one of the major drivers for this market is the integration of digital health in rapid diagnostics for bacterial disease.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Accelerate Diagnostics Inc.
- Becton Dickinson and Co.
- Bio Rad Laboratories Inc.
- bioMerieux SA
- Bruker Corp.
- Danaher Corp.
- DiaSorin SpA
- EKF Diagnostics Holdings Plc
- F. Hoffmann La Roche Ltd.
- GENERI BIOTECH s.r.o.
- Great Basin Scientific
- Hologic Inc.
- Meridian Bioscience Inc.
- QIAGEN NV
- Quest Diagnostics Inc.
- Revvity Inc.
- Siemens AG
- T2 Biosystems Inc.
- Takara Bio Inc.
